What is the recommended diagnostic work‑up and management strategy for a splenic artery aneurysm, including indications for intervention versus surveillance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Splenic Artery Aneurysm: Diagnostic Work-up and Management

For splenic artery aneurysms (SAAs), intervene on aneurysms ≥2.0 cm in diameter, all symptomatic aneurysms, all pseudoaneurysms regardless of size, and all aneurysms in women of childbearing age or pregnant women, with endovascular therapy as the first-line treatment approach.

Diagnostic Work-up

Initial imaging should be CT angiography (CTA), which provides optimal visualization of aneurysm size, morphology (saccular vs fusiform), location along the splenic artery, calcification pattern, and relationship to surrounding structures 1. Most SAAs are discovered incidentally during abdominal imaging for unrelated indications 1, 2.

Key diagnostic features to document:

  • Maximum diameter (critical for treatment decisions)
  • Location: proximal, mid, distal splenic artery, or hilum 3
  • Morphology: saccular (72% of cases) vs fusiform 4
  • Calcification: present in 88% of cases 4
  • True aneurysm vs pseudoaneurysm (pseudoaneurysms require intervention regardless of size) 5, 6

Indications for Intervention vs Surveillance

Absolute Indications for Intervention:

  1. Symptomatic aneurysms (abdominal pain, rupture) 1, 6
  2. Ruptured aneurysms (emergency intervention required) 1
  3. Aneurysms ≥2.0 cm diameter 1, 7, 8, 5, 6
  4. All pseudoaneurysms regardless of size 5, 6
  5. Women of childbearing age or pregnant women (due to 70% maternal and >90% fetal mortality with rupture) 1, 7, 8, 6
  6. Patients with portal hypertension 1, 6
  7. Patients awaiting liver transplantation 6

Surveillance Protocol for Aneurysms <2.0 cm:

For asymptomatic SAAs <2.0 cm in low-risk patients (men, non-pregnant women beyond childbearing age, no portal hypertension):

  • Serial imaging with CTA or ultrasound
  • Annual follow-up initially to establish growth rate 9, 4
  • Mean growth rate is slow: 0.17 mm/year for aneurysms 10-19 mm 4
  • Intervene if growth documented or if aneurysm reaches 2.0 cm threshold 9, 4

Treatment Approach

Endovascular therapy is the first-line treatment with 75-100% technical success rates and significantly lower morbidity/mortality compared to open surgery 2, 9, 5, 3.

Endovascular Options (in order of preference):

  1. Coil embolization of the aneurysm sac (most common approach) 2, 9, 5, 3
  2. Covered stent placement to exclude the aneurysm while preserving splenic artery flow 2, 3
  3. Proximal and distal artery embolization (sacrifice splenic perfusion, relying on collaterals) 9, 3
  4. Combination techniques (dual microcatheter with coils + Onyx) for complex anatomy 10

Technical success rate: 94.7% 3 Perioperative complication rate: 25% (mostly minor splenic infarction) 2, 3 30-day mortality: 0-1.2% for elective cases 2, 9

Open Surgery Reserved For:

  • Failed endovascular attempts 2
  • Giant aneurysms >5 cm where anatomy precludes endovascular approach 11
  • Ruptured aneurysms with hemodynamic instability requiring immediate control 1

Open options include: aneurysmectomy with arterial reconstruction, splenic artery ligation with/without splenectomy, depending on aneurysm location 12, 6, 11.

Critical High-Risk Populations

Pregnant Women:

This is the highest-risk scenario. Rupture during pregnancy carries 70% maternal mortality and >90% fetal mortality 1, 7, 8.

  • Prophylactic intervention recommended for any SAA ≥2.0 cm detected pre-conception or during pregnancy 7, 8
  • Critical caveat: 50% of SAAs that rupture during pregnancy are <2.0 cm 7, 8, making the size threshold controversial
  • Consider intervention for smaller aneurysms in pregnant women, particularly in third trimester when splenic blood flow is maximal 7
  • Endovascular embolization preferred over surgery during pregnancy 7

Portal Hypertension/Cirrhosis:

These patients have increased rupture risk and should undergo intervention at the 2.0 cm threshold 1, 7, 8, 6. SAA rupture in cirrhotic patients presents with the "double rupture phenomenon" in 25% of cases—initial contained bleed followed by catastrophic rupture 7.

Common Pitfalls

  1. Underestimating rupture risk in pregnancy: Don't rely solely on size criteria; consider prophylactic treatment for any detectable SAA in women planning pregnancy 7, 8

  2. Missing pseudoaneurysms: These require intervention regardless of size due to higher rupture risk 5, 6

  3. Inadequate follow-up: Even after successful endovascular treatment, imaging surveillance is needed to detect recanalization or growth 2, 9

  4. Delaying intervention in symptomatic patients: Any abdominal pain in a patient with known SAA warrants urgent evaluation and likely intervention 1

  5. Ruptured SAA mortality: Emergency rupture carries 10-38% mortality even with treatment 1, 9, emphasizing the importance of elective intervention when indicated

References

Research

Decision-making and therapeutic options in intact splenic artery aneurysms: single-center experience and literature review.

International angiology : a journal of the International Union of Angiology, 2020

Research

Splenic artery aneurysm.

Revista do Colegio Brasileiro de Cirurgioes, 2016

Research

The contemporary management of splenic artery aneurysms.

Journal of vascular surgery, 2011

Research

Giant splenic aneurysm repair with a staged hybrid approach.

Journal of vascular surgery cases and innovative techniques, 2025

Research

Surgical management of splenic artery aneurysm.

Annals of medicine and surgery (2012), 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.